Earth Science Tech Inc. (OTC: ETST) is leveraging a diversified, vertically integrated business model that spans pharmaceuticals, telemedicine, retail, and real estate, contributing to fiscal 2026 revenue growth of 8% alongside increases in gross profit and net income. Through subsidiaries including Peak Curative, RxCompound, and Mister Meds, the company connects telemedicine consultations, compounding pharmacies, and medication fulfillment within an end-to-end healthcare ecosystem. This integrated model supports product development and diversification, allowing ETST to generate revenue by supporting other digital health companies while expanding its own reach.
Its MOCTeledoc platform provides B2B technology and clinical staffing solutions, enabling the company to offer services to other digital health firms. The vertical integration strategy is central to ETST's value proposition, as it seamlessly integrates patient care from consultation to fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, with a principal operating strategy to build a vertically integrated healthcare platform. The core of the company’s value proposition is the synergy of specialized subsidiaries, combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. For more details, visit the company's newsroom at https://ibn.fm/ETST.
The latest news and updates relating to ETST are available in the company’s newsroom. To view the full article on BioMedWire, visit https://ibn.fm/I1F0R. Earth Science Tech's ability to generate revenue growth through its integrated model highlights the importance of vertical integration in the healthcare sector, as it allows the company to capture more value across the care delivery chain.
